MALT lymphoma CT: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{MALT lymphoma}}
{{MALT lymphoma}}
{{CMG}}{{AE}}{{SR}}
{{CMG}}{{AE}}{{SR}}, {{AY}}


==Overview==
==Overview==

Latest revision as of 19:08, 18 December 2017

MALT lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating MALT Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Upper GI Endoscopy

CT

MRI

Endoscopic Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

MALT lymphoma CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of MALT lymphoma CT

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMALT lymphoma CT

CDC on MALT lymphoma CT

MALT lymphoma CT in the news

on MALT lymphoma CT

Directions to Hospitals Treating MALT lymphoma

Risk calculators and risk factors for MALT lymphoma CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2], Ahmed Younes M.B.B.CH [3]

Overview

Chest, abdominal, and/or pelvic CT scan is generally performed to evaluate the extent and spread of MALT lymphoma.[1] If the disease is limited to the stomach (which is assessed with computed tomography), then 70-80% of patients will have a complete regression on treatment with antibiotic eradication of H. pylori.[2]

CT

Chest, abdominal, and/or pelvic CT scan is generally performed to evaluate the extent and spread of MALT lymphoma.[1] If the disease is limited to the stomach (which is assessed with computed tomography), then 70-80% of patients will have a complete regression on treatment with antibiotic eradication of H. pylori.[2]

References

  1. 1.0 1.1 Nasser QJ, Pfeiffer ML, Romaguera J, Fowler N, Debnam JM, Samaniego F; et al. (2014). "Clinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphoma". Leuk Lymphoma. 55 (5): 1013–7. doi:10.3109/10428194.2013.826353. PMID 23879202.
  2. 2.0 2.1 Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M (1995). "Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group". Lancet. 345 (8965): 1591–4. PMID 7783535.


Template:WikiDoc Sources